Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, JAMA, vol.308, issue.10, p.998, 2012. ,
Impact of cardiac rehabilitation referral on one-year outcome after discharge of patients with acute myocardial infarction, European Journal of Preventive Cardiology, vol.26, issue.2, pp.138-144, 2018. ,
Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI, Journal of the American College of Cardiology, vol.64, issue.20, pp.2101-2108, 2014. ,
Population Trends in Percutaneous Coronary Intervention, Journal of the American College of Cardiology, vol.61, issue.12, pp.1222-1230, 2013. ,
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries, European Heart Journal, vol.35, issue.29, pp.1957-1970, 2014. ,
Prognostic significance of nonfatal myocardial reinfarction, Journal of the American College of Cardiology, vol.15, issue.2, pp.253-258, 1990. ,
Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction, The American Journal of Cardiology, vol.113, issue.2, pp.229-235, 2014. ,
Impact of Previous Stroke on Short-Term Myocardial Reinfarction in Patients With Acute ST Segment Elevation Myocardial Infarction, Medicine, vol.95, issue.6, p.e2742, 2016. ,
Reduced risk of recurrent myocardial infarction in homozygous carriers of the chromosome 9p21 rs1333049 C risk allele in the contemporary percutaneous coronary intervention era: a prospective observational study, BMJ Open, vol.4, issue.8, pp.e005438-e005438, 2014. ,
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST, American Heart Journal, vol.161, issue.2, pp.283-290, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00698395
Esc guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of cardiology (ESC), Eur Heart J, pp.119-77, 2017. ,
A meta-analysis of the association between adherence to drug therapy and mortality, BMJ, vol.333, issue.7557, p.15, 2006. ,
Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention & Rehabilitation of the ESC. Challenges in secondary prevention of cardiovascular diseases: a review of the current practice, Int J Cardiol, vol.180, pp.114-123, 2015. ,
Five-year evolution of reperfusion strategies and early mortality in patients with ST-segment elevation myocardial infarction in France, European Heart Journal: Acute Cardiovascular Care, vol.6, issue.7, pp.573-582, 2015. ,
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies, International Journal of Surgery, vol.12, issue.12, pp.1495-1499, 2014. ,
Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study, Circulation, vol.127, issue.6, pp.673-680, 2013. ,
Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction, Heart, vol.104, issue.19, pp.1583-1592, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02341884
Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association, European Heart Journal: Acute Cardiovascular Care, vol.6, issue.1, pp.34-59, 2016. ,
The use of propensity score methods with survival or time?to?event outcomes: reporting measures of effect similar to those used in randomized experiments, Statistics in Medicine, vol.33, issue.7, pp.1242-1258, 2013. ,
Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study), The American Journal of Cardiology, vol.121, issue.8, pp.897-902, 2018. ,
Clinical features of early recurrent myocardial infarction, Heart and Vessels, vol.24, issue.5, pp.347-351, 2009. ,
?Heart without smoke? educational campaign ? the role of patient education in secondary prevention of cardiovascular disease, Kardiologia Polska, vol.76, pp.125-129, 2017. ,
Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion, BMC Cardiovascular Disorders, vol.17, issue.1, p.54, 2017. ,
Exploration of the methodological quality and clinical usefulness of a cross-sectional sample of published guidance about exercise training and physical activity for the secondary prevention of coronary heart disease, BMC Cardiovascular Disorders, vol.17, issue.1, p.153, 2017. ,
Predictors of cardiac rehabilitation attendance following primary percutaneous coronary intervention for ST-elevation myocardial infarction in Australia, Nursing & Health Sciences, vol.18, issue.2, pp.230-237, 2016. ,
Evidence to service gap: cardiac rehabilitation and secondary prevention in rural and remote Western Australia, BMC Health Services Research, vol.18, issue.1, p.64, 2018. ,
Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, vol.140, issue.11, pp.177-232, 2019. ,
, , 2020.